TY - JOUR T1 - Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018 JF - The Journal of Rheumatology JO - J Rheumatol SP - 1355 LP - 1359 DO - 10.3899/jrheum.181099 VL - 46 IS - 10 AU - Alessandro Chiarotto AU - Ulrike Kaiser AU - Ernest Choy AU - Robin Christensen AU - Philip G. Conaghan AU - Mary Cowern AU - Michael Gill AU - Maarten de Wit AU - Elizabeth Gargon AU - Ben Horgan AU - Jamie J. Kirkham AU - Lee S. Simon AU - Jasvinder A. Singh AU - Peter Tugwell AU - Dennis C. Turk AU - Philip J. Mease Y1 - 2019/10/01 UR - http://www.jrheum.org/content/46/10/1355.abstract N2 - Objective. Establishing a research agenda on standardizing pain measurement in clinical trials in rheumatic and musculoskeletal diseases (RMD).Methods. Discussion during a meeting at the Outcome Measures in Rheumatology (OMERACT) 2018, prepared by a systematic review of existing core outcome sets and a patient online survey.Results. Several key questions were debated: Is pain a symptom or a disease? Are pain core (sub)domains consistent across RMD? How to account for pain mechanistic descriptors (e.g., central sensitization) in pain measurement?Conclusion. Characterizing and assessing the spectrum of pain experience across RMD in a standardized fashion is the objective of the OMERACT Pain Working Group. ER -